CVBF future perspectives. An interview to the CEO, Donato Bonifazi
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) has been included in the Financial Times (FT) 1000 report, a list of the companies in 31 European countries that have achieved the highest percentage growth in revenues between 2013 and 2016. We have asked Donato Bonifazi, CEO at CVBF, about the future perspectives and projects for CVBF: [...]
